Medication Management of Antipsychotic-Induced Weight Gain in Children and Teens
Second-generation antipsychotics routinely breach the FDA\u2019s level of concern of >7% body weight gain. This article examines the efficacy and safety of using off-label medications, such as metformin, to manage this side effect.CME: Take the CME Post-Test for this episode (https://www.thecarlatcmeinstitute.com/course/view.php?id=53) \xa0Published On: 07/25/2022Duration: 13 minutes, 19 secondsReferenced Article: \u201cEating Disorders in Children and Adolescents (https://www.thecarlatreport.com/newsletter-issue/ccpr13n5-6/) \u201d The Carlat Child Psychiatry Report, July/August/September 2022Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity